A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma

A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma

Item
http://www.wikidata.org/entity/Q28304566
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewA phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).Emerging tyrosine kinase inhibitors for the treatment of renal cancer.Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapies.Benefit, Risk, and Outcomes in Drug Development: A Systematic Review of Sunitinib.Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.Sunitinib in kidney cancer: 10 years of experience and development.A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer.Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report.Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
P2860

A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma

Item
http://www.wikidata.org/entity/Q28304566
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase I, open-label study of ...... advanced renal cell carcinoma
@ast
A phase I, open-label study of ...... advanced renal cell carcinoma
@en
A phase I, open-label study of ...... advanced renal cell carcinoma
@nl
type
label
A phase I, open-label study of ...... advanced renal cell carcinoma
@ast
A phase I, open-label study of ...... advanced renal cell carcinoma
@en
A phase I, open-label study of ...... advanced renal cell carcinoma
@nl
prefLabel
A phase I, open-label study of ...... advanced renal cell carcinoma
@ast
A phase I, open-label study of ...... advanced renal cell carcinoma
@en
A phase I, open-label study of ...... advanced renal cell carcinoma
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
A phase I, open-label study of ...... advanced renal cell carcinoma
@en
P2093
P2860
P304
P31
P356
10.1016/J.CLGC.2013.11.007
P407
P433
P478
P50
P577
P5875
P698
P932